Skip to Content

Notice

Memorandum of Understanding Between the Food and Drug Administration, Center for Biologics Evaluation and Research, and the National Institutes of Health, National Institute of Neurological Disorders and Stroke

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Food and Drug Administration, Center for Biologics Evaluation and Research (FDA/CBER), and the National Institutes of Health, National Institute of Neurological Disorders and Stroke (NIH/NINDS). The purpose of this MOU is to provide a framework for coordination and collaborative efforts between these two entities, which are both components of the Department of Health and Human Services. This MOU also provides the principles and procedures by which information sharing between FDA/CBER and NIH/NINDS units shall take place.

DATES:

The agreement became effective February 12, 2002.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

For FDA/CBER: Kimberly Benton, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, WOC1/rm. 209N, Rockville, MD 20852, 301-827-5102.

For NIH/NINDS: Robert Finkelstein, Extramural Research, Neuroscience Center, National Institutes of Health, 6001 Executive Blvd., rm. 2143, Bethesda, MD 20892, 301-496-9248.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU.

Start Signature

Dated: September 8, 2005.

Jeffrey Shuren,

Assistant Commissioner for Policy.

End Signature Start Printed Page 54927

Start Printed Page 54928

Start Printed Page 54929

Start Printed Page 54930

Start Printed Page 54931

Start Printed Page 54932

Start Printed Page 54933

Start Printed Page 54934

Start Printed Page 54935

Start Printed Page 54936

Start Printed Page 54937

Start Printed Page 54938

Start Printed Page 54939

Start Printed Page 54940

Start Printed Page 54941

Start Printed Page 54942

End Supplemental Information

BILLING CODE 4160-01-S

[FR Doc. 05-18514 Filed 9-16-05; 8:45 am]

BILLING CODE 4160-01-C